Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03468933 · ClinicalTrials.gov registry record · Phase 4
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
A Phase 4 study, sponsored by Tulane University.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT03468933 is a Phase 4 study that has completed, run by Tulane University. The registered enrollment target is 32 participants.
The verdict
NCT03468933, a Phase 4 study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management of empyema or complicated parapneumonic effusion (CPPE) in adults.
Interventions
- DRUG tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase)
- PROCEDURE Medical Thoracoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03468933
The ClinicalTrials.gov registry entry for NCT03468933 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase) is the first listed.
NCT03468933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03468933 about?
NCT03468933 is a clinical study titled "Fibrinolysis Compared to Thoracoscopy for Pleural Infection". The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management...
What is the current status of trial NCT03468933?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2017-11-01. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT03468933?
The interventions under investigation include: tissue plasminogen activator (tPA) and human recombinant deoxyribonuclease (DNase) (DRUG), Medical Thoracoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03468933?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.